Radiation Retinopathy 15 Years after Orbital Irradiation for Thyroid Orbitopathy

K. Hurtikova; G. von Arx; N. Fichter; H. Gerding

doi:10.1055/s-0042-102610

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd 2016; 233(04): 508-510
DOI: 10.1055/s-0042-102610

Der interessante Fall

Georg Thieme Verlag KG Stuttgart · New York

Radiation Retinopathy 15 Years after Orbital Irradiation for Thyroid Orbitopathy

Strahlenretinopathie 15 Jahre nach Orbita-Bestrahlung bei endokriner Orbitopathie

K. Hurtikova^*

¹Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)

,

G. von Arx

²Admedico Augenzentrum, Olten, Switzerland (Director: Dr. Georg von Arx)

,

N. Fichter

²Admedico Augenzentrum, Olten, Switzerland (Director: Dr. Georg von Arx)

,

H. Gerding^*

¹Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)

³Department of Ophthalmology, University of Münster, Münster (Director: Prof. Dr. Nicole Eter)

› Author Affiliations

Abstract

Full Text

References

References
1 Bradley EA, Gower EW, Bradley DJ et al. Orbital radiation for Graves ophthalmopathy. A report by the American Academy of Ophthalmology. Ophthalmology 2008; 115: 398-409
2 Tanda ML, Bartalens L. Efficacy and safety of orbital radiotherapy for Gravesʼorbitopathy. J Clin Endocrinol Metab 2012; 97: 3857-3865
3 Viani GA, Boin AC, De Fendi LI et al. Radiation therapy for Gravesʼ ophthalmopathy: a systemic review and meta-analysis of randomized controlled trials. Arq Bras Oftalmol 2012; 75: 324-332
4 Bartalena L, Baldeschi L, Dickinson A et al. Consensus statement of the European Group on Gravesʼorbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008; 158: 273-285
5 Bartalena L, Marcocci C, Chiovato L et al. Orbital cobalt irradiation combined with systemic corticosteroids for Gravesʼs ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983; 56: 1139-1144
6 Marcocci C, Bartalena L, Bogazzi F et al. Orbital radiotherapy combined with high-dose systemic glucocorticosteroids for Graveʼs ophthalmopathy in more effective than orbital radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 1991; 14: 853-860
7 Donaldson SS, Bagshaw MA, Driss JP. Supervoltage orbital radiotherapy for Gravesʼ ophthalmopathy. J Clin Endocrinol Metab 1973; 37: 276-285
8 Kinyoun JL, Kalina RE, Brower SA et al. Radiation retinopathy after orbital irradiation for Gravesʼ ophthalmopathy. Arch Ophthalmol 1984; 102: 1473-1476
9 Kinyoun JL, Chittum ME, Wells CG. Photocoagulation treatment of radiation retinopathy. Am J Ophthalmol 1988; 105: 470-478
10 Kinyoun JL, Orcutt JC. Radiation retinopathy. JAMA 1987; 258: 610-611
11 Marquez SD, Lum BL, McDougall IR et al. Long-term results of irradiation for patients with progressive Gravesʼ ophthalmopathy. Int J Radiat Oncol Biol Phys 2001; 51: 766-774
12 Robertson DM, Buettner H, Gorman CA et al. Retinal microvascular abnormalities in patients treated with external radiation for Graves ophthalmopathy. Arch Ophthalmol 2003; 121: 652-657
13 Gorman CA, Garrity JA, Fatourechi V et al. The aftermath of orbital radiotherapy for Gravesʼ ophthalmopathy. Ophthalmology 2002; 109: 2100-2107
14 Marcocci C, Bartanlena L, Roccchi R et al. A long-term safety of orbital radiotherapy for Gravesʼ ophthalmopathy. J Clin Endocrinol Metab 2003; 88: 3561-3566
15 Wakelkamp IM, Tan H, Saeed P et al. Orbital irradiation for Gravesʼ ophthalmopathy. Is it safe? A long-term follow-up study. Ophthalmology 2004; 111: 1557-1562
16 Kaushik M, Pulido JS, Schild SE, Stafford S. Risk of radiation retinopathy in patients with orbital and ocular lymphoma. Int J Radiat Oncol Biol Phys 2012; 84: 1145-1150
17 Monroe AT, Bhandare N, Morris CG et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005; 61: 856-864
18 Parsons T, Bova FJ, Fitzgerald CR et al. Radiation retinopathy after external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 765-773